000 | 01032 a2200289 4500 | ||
---|---|---|---|
005 | 20250513092619.0 | ||
264 | 0 | _c19960823 | |
008 | 199608s 0 0 spa d | ||
022 | _a0212-7199 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMarcos Sánchez, F | |
245 | 0 | 0 |
_a[Danazol and cholestatic hepatitis]. _h[electronic resource] |
260 |
_bAnales de medicina interna (Madrid, Spain : 1984) _cApr 1996 |
||
300 |
_a202-3 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Letter; Comment | ||
650 | 0 | 4 |
_aAnemia, Aplastic _xdrug therapy |
650 | 0 | 4 |
_aChemical and Drug Induced Liver Injury _xetiology |
650 | 0 | 4 |
_aCholestasis _xchemically induced |
650 | 0 | 4 |
_aDanazol _xadverse effects |
650 | 0 | 4 |
_aEstrogen Antagonists _xadverse effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aPurpura, Thrombocytopenic _xdrug therapy |
700 | 1 | _aJuarez Ucelay, F | |
700 | 1 | _aDurán Pérez-Navarro, M A | |
773 | 0 |
_tAnales de medicina interna (Madrid, Spain : 1984) _gvol. 13 _gno. 4 _gp. 202-3 |
|
999 |
_c8685815 _d8685815 |